Literature DB >> 5940225

Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone).

S D Mohamed, R S Chapman, J Crooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5940225      PMCID： PMC1844772          DOI： 10.1136/bmj.1.5503.1581

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  13 in total

1.  TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS.

Authors:  R DOLL; I D HILL; C F HUTTON
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

2.  Reversible amyotrophy complicating treatment with fludrocortisone.

Authors:  K MACLEAN; P H SCHURR
Journal:  Lancet       Date:  1959-04-04       Impact factor: 79.321

3.  [Hypokalemia and alkalosis caused by excessive ingestion of extract of licorice and bicarbonated water. Pseudo-syndrome of Conn].

Authors:  M JENNY; A F MULLER; J FABRE; R S MACH
Journal:  Schweiz Med Wochenschr       Date:  1961-07-29

4.  Dexamethasone myopathy.

Authors:  D N GOLDING; T B BEGG
Journal:  Br Med J       Date:  1960-10-15

5.  Idiopathic myoglobinuria.

Authors:  E N THOMPSON; P M BROUGHTON
Journal:  Br Med J       Date:  1961-09-02

6.  [Quadriplegia with hypokalemia and metabolic alkalosis secondary to massive and prolonged ingestion of licorice extract in an alcoholic and potomanic psychopath].

Authors:  P MOLLARET; M GOULON; M TOURNILHAC
Journal:  Bull Mem Soc Med Hop Paris       Date:  1960 Apr 1-8

7.  Necrosis and regeneration of skeletal muscles in cortisone-treated rabbits.

Authors:  J T ELLIS
Journal:  Am J Pathol       Date:  1956 Sep-Oct       Impact factor: 4.307

8.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

9.  Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.

Authors:  L Horwich; R Galloway
Journal:  Br Med J       Date:  1965-11-27

10.  Hypokalemic myopathy with myoglobinuria associated with licorice ingestion.

Authors:  E G Gross; J D Dexter; R G Roth
Journal:  N Engl J Med       Date:  1966-03-17       Impact factor: 91.245
View more
  31 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

2.  Carbenoxolone-induced hypokalaemia simulating Guillain-Barré syndrome.

Authors:  A Royston; B J Prout
Journal:  Br Med J       Date:  1976-07-17

Review 3.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Complications of carbenoxolone therapy.

Authors:  G J Davies; J Rhodes; B J Calcraft
Journal:  Br Med J       Date:  1974-08-10

5.  Clinical trial of deglycyrrhizinized liquorice in gastric ulcer.

Authors:  A G Turpie; J Runcie; T J Thomson
Journal:  Gut       Date:  1969-04       Impact factor: 23.059

Review 6.  Carbenoxolone sodium.

Authors:  M J Langman
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

7.  Duogastrone-induced hypokalaemic nephropathy and myopathy with myoglobinuria.

Authors:  A B Mitchell
Journal:  Postgrad Med J       Date:  1971-12       Impact factor: 2.401

8.  [Influence of carbenoxolone therapy on the renin-angiotensin-aldosterone system].

Authors:  C Werning; O Stadelmann; S E Miederer; W Vetter; H U Schweikert; D Stiel; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1971-12-01

Review 9.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 10.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.